Effect of yearly mass drug administration with diethylcarbamazine and albendazole on bancroftian filariasis in Egypt: a comprehensive assessment.
BACKGROUND
Egypt was one of the first countries to implement a national programme to eliminate lymphatic filariasis based on WHO's strategy of repeated rounds of mass drug administration (MDA) with diethylcarbamazine and albendazole (target population, 2.5 million in 181 localities). We assessed the effect of five yearly rounds of MDA on filariasis in four sentinel villages in Egypt.


METHODS
We studied two areas with different infection rates before MDA: the Qalubyia study area had a low infection rate because of previous treatment with diethylcarbamazine; this was typical of most filariasis-endemic villages in Egypt before MDA. The Giza study area had a high baseline infection rate. We undertook repeated surveys in villages for treatment compliance and tests for microfilaraemia and circulating filarial antigenaemia, antibodies to filarial antigen Bm14 in schoolchildren, and infections in indoor-resting mosquitoes (assessed by PCR).


RESULTS
MDA compliance rates were excellent (>80%). In Giza after MDA, prevalence rates of microfilaraemia and circulating filarial antigenaemia fell from 11.5% to 1.2%, and from 19.0% to 4.8%, respectively (p<0.0001). Corresponding rates in Qalubyia fell from 3.1% to 0% and 13.6% to 3.1%, respectively (p<0.0001). Rates of antifilarial antibody and circulating filarial antigenaemia in schoolchildren (aged about 7-8 years), fell from 18.3% to 0.2% (p<0.0001) and from 10.0% to 0.4% (p<0.0001) in Giza, respectively, and from 1.7% to 0% and 1.7% to 0% (both p=0.13) in Qalubyia, respectively. Mosquito infection rates fell from 3.07% (95% CI 2.38-3.88) to 0.19% (0.08-0.38) in Giza and from 4.37% (3.07-5.99) to 0% (0-0.05) in Qalubyia.


CONCLUSIONS
MDA greatly affects variables related to infection (microfilaraemia and circulating filarial antigenaemia prevalence rates) and transmission (antifilarial antibodies in young children and mosquito infection rates). Our results suggest that after five rounds of MDA filariasis is likely to have been eliminated in most endemic localities in Egypt.
Ramzy
Reda M R
RM
Research and Training Centre on Vectors of Diseases, Ain Shams University, Cairo, Egypt.
El Setouhy
Maged
M
Helmy
Hanan
H
Ahmed
Ehab S
ES
Abd Elaziz
Khaled M
KM
Farid
Hoda A
HA
Shannon
William D
WD
Weil
Gary J
GJ
D015766:Albendazole / Q000627:therapeutic use*; D000818:Animals; D002648:Child; D002675:Child, Preschool; D003430:Cross-Sectional Studies; D003465:Culex / Q000469:parasitology; D004049:Diethylcarbamazine / Q000627:therapeutic use*; D004534:Egypt / Q000453:epidemiology; D005368:Filariasis / Q000453:epidemiology / Q000517:prevention & control* / Q000635:transmission; D005369:Filaricides / Q000627:therapeutic use*; D006801:Humans; D011314:Preventive Health Services / Q000458:organization & administration* / Q000706:statistics & numerical data; D018571:Sentinel Surveillance; D014958:Wuchereria bancrofti / Q000472:pathogenicity*
D005369:Filaricides; D015766:Albendazole; D004049:Diethylcarbamazine